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Abstract
Sialylated milk oligosaccharides (SMOs) have a multifunctional health benefit, yet the molecular details underlying their
potential role in modulating intestinal maturation remains unknown. To test the hypothesis that sialyllactose (SL) may mediate
intestinal maturation and function through controlling neuronal function, studies were carried out where the diet of postnatal
piglets was supplemented with a mixture of 3′- and 6′-sialyllactose from postnatal day 3 to 38. Gene transcription pathways
regulating enteric nervous system function, polysialic acid (polySia) synthesis, and cell proliferation were quantified. Our new
findings show that SL intervention: (1) upregulated the level of gene and protein expression of the glial-derived neurotrophic
factor (GDNF) in the ileum; (2) upregulated phosphorylation of the cAMP responsive element-binding protein (CREB), the
downstream target of GDNF signaling pathway; (3) promoted cell proliferation based on an increase in the number and density of
Ki-67 positive cells in the crypts; (4) increased the crypt width in the ileum by 10%, while gene markers for the functional cells
were not affected; (5) upregulated mRNA expression level of ST8Sia IV, a key polysialyltransferase responsible for synthesis of
polySia-NCAM; (6) reduced the incidence and severity of diarrhea. These results show that SL promotes intestinal maturation in
neonatal piglets by upregulating GDNF, synthesis of polySia and CREB-interactive pathway.
Keywords GDNF signaling pathway . CREB . Polysialic acid . ST8Sia IV . Enteric nervous system (ENS)
Introduction
Maturation of the intestine during infancy relies entirely on
adequate nutritional support. In humans and mammals, the
gastrointestinal tract is functionally immature and immune
incompetent at birth but undergoes rapid growth and matura-
tion after birth [1]. This developmental process is induced by
providing nutrients which, in turn, promotes structural and
functional development of the intestine, including digestive
and absorptive capacity and intestinal barrier function [2].
Multiple studies have demonstrated the beneficial effects of
breast-feeding in preventing morbidity and mortality from
necrotizing enterocolitis and diarrhea in both human infants
and other mammals. This impacts long-term health and dis-
ease, of which inflammatory bowel disease is a serious con-
sequence [3]. The benefits of human milk on intestinal devel-
opment are related to its nutritional composition and to the
biological activities of specific biochemical components.
One such class of biochemical or nutritional compounds is
the human milk oligosaccharides (HMOs), which are the third
largest component in human milk after lactose and lipids, at
levels of 20–25 g/L in colostrum and 5–20 g/L in mature milk
[4]. Approximately 10~30% of the HMOs are sialylated milk
oligosaccharides (SMOs), which is a ~ 100-fold higher con-
centration than present in bovine milk or infant formulas [5,
6]. The most abundant human SMOS is sialyllactose (SL),
which is found predominantly in two forms, 3′-SL and 6′-
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SL, with the number denoting the position of the Sia mono-
saccharide linkage to lactose [6]. The concentrations of 6′-SL
are the major SL in human breast milk while, in contrast, 3′-
SL is the predominant SL in infant formula. The level of 6′-SL
in human milk declines during lactation from 500 mg/L at
1 month to 250 mg/L at 2 months, while the concentration
of 3′-SL remains relatively constant at ca. 220 mg/L through-
out lactation [7]. However, the biological functions of 3′-SL
and 6′-SL are similar in supporting resistance to pathogens [8],
favoring the growth of beneficial intestinal bacteria [9] and
promoting neural function and cognitive development [5].
Molecular mechanism studies underlying the protective effect
of SL on intestinal infections, bacterial flora, and maturation
have been focused primarily on in vitro studies, including the
role of the interaction of the SL motif present in the GM3
ganglioside, its inhibition of the in vitro phosphorylation of
the epidermal growth factor receptor [10], and the effect of SL
on the growth-related characteristics of intestinal cells [11].
The sialic acids (Sia) are a class of 9-carbon acidic amino
sugars that are a marker of SMOs. High concentrations of Sia
are found in HMOs, brain gangliosides, sialylated glycopro-
teins, and the polysialic acid (polySia) glycans, which
posttranslationally modifies the cell membrane-associated
neural cell adhesion molecules (NCAMs) [12] to mediate a
number of critically important cell-to-cell interactions in the
brain and immune system, as reviewed in references [13–16].
CMP-Sia (CMP-Neu5Ac) is the activated Sia precursor re-
quired for catalyzing synthesis of all sialylated glycans, includ-
ing the polySia glycan, which posttranslationally polysialylates
the cell membrane-associated NCAMs, synaptic cell adhesion
molecules (SynCAM), neuropilie2 (NRP2), theα-subunit of the
sodium channel [17], CCR7 [18], and the E-selectin ligand [19].
Recently, we reported that dietary intervention with the Sia-rich
glycoprotein, lactoferrin (Lf), upregulated intestinal gene ex-
pression of the brain-derived neurotrophic factors, BDNF, and
alkaline phosphatase activity to alleviate early weaning diarrhea
in postnatal piglets [20]. There is, however, a dearth of informa-
tion on understanding the molecular and cellular mechanisms
underlying how sialylated HMOs modulate the enteric nervous
system (ENS), intestinal maturation, structure, and function
in vivo. The objective of the present study was to determine
the molecular and cellular mechanisms underlying how SL
modulates the intestinal ENS to promote intestinal maturation
in neonatal piglets, a preferred animal model for translational
studies relevant for the human infant [21].
Materials and Methods
Neonatal Piglets
Male 3-day-old domestic piglets (Sus scrofa landrace × large
white F1) were purchased from a commercial pig farm in
Xiamen City, China. Based on body weight and litter infor-
mation, the piglets were randomly divided into the control
(n = 17) and SL treatment groups (n = 17). All animals were
housed in pairs in a home pen in a temperature-controlled
room (2 °C) with a relative humidity of 50–60% on a 12-h
light (08:00–20:00) and dark (20:00~08:00) cycle, as previ-
ously described [20]. The home pens contained a “nest,”
consisting of a rubber tire covered with a clean towel, a heat
lamp over the nest, and an identical wooden toy hanging in the
home pen. All participating personnel were double blinded as
to the diet each piglet received during the study. The experi-
mental protocol was carried out in accordance with guidelines
established by the National Natural Science Foundation of
China and approved by the Animal Ethics Committee of
Xiamen University.
Animal Feeding
3′-SL and 6′-SL (Gene Chem Inc. South Korea) at a ratio of
5:1 were blended into the piglets’milk replacer (Feed &Grow
International Co. Ltd. China) at a concentration of 1.71 g/L for
the SL intervention group. The group without any supplemen-
tation of SL was considered the control group. Quantitative
analyses of the total Sia concentration in the final experimen-
tal diets were 875 mg/L in the SL treatment group (exoge-
nously added), and 140 mg/L in the control group, which
was derived from the piglets’ milk replacement (endogenous
level). These SL concentrations represent an approximate Sia
intake of 240 and 40 mg/kg body weight/day, respectively.
To maintain normal growth rates, the piglets received
285 mL/kg body weight/day from postnatal day 3 to 15, and
230 mL/kg body weight/day for the remaining 23 days. The
duration of SL intervention was from 3 to 38 days of age.
Thirty-eight-day-old postnatal pigs are approximately equiva-
lent to 10 months old of human infants [21]. Feeding times
were at 08:00, 13:00, 18:00, and 22:30 h, with an extra 50 mL
milk/pig supplied at the last feeding. Body weights were mea-
sured eachmorning before feeding using a digital scale (PRIS-
Scale model: XK 3116, Chengdu Pris Electronic Co. Ltd.,
China). The milk intake, health status, stool consistency, and
any medications were recorded daily. Diarrhea is defined as
the passage of three or more loose or liquid stools per day, or
more frequent passage than is normal for individual piglets.
Sample Collection
On a postnatal day 38, the piglets were euthanized with sodi-
um pentobarbital (100 mg/kg body). Samples were collected
as previously described [20]. In this procedure, the entire
small intestine, from pyloric to the ileocecal valve, was imme-
diately removed and the total length measured. Three seg-
ments of the small intestine, based on their anatomical loca-
tion, were collected. Each segment was gently flushed with
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diethylpyrocarbonate (DEPC): water (1:1000 v/v) at 2–4° C
and ~ 50 mg of each tissue section was stored in RNA Later
(Invitrogen, USA) for the subsequent quantitative-PCR (q-
PCR) analyses. Samples for histological analyses were fixed
in a solution of 4% paraformaldehyde. The remaining intesti-
nal samples, and the contents of the colon, were collected and
frozen at − 80 °C for subsequent protein and microbiota
analyses.
q-PCR Analyses of the Target Gene mRNA Levels
in the Ileum
The q-PCR procedure and data analyses were carried out as
previously described [20]. In this method, the total RNAwas
extracted from ileum tissue (10–20 mg) using the Agencourt
RNAdvance Tissue Kit (Beckman, USA) and then converted
into cDNA following the instruction of RevertAid First strand
cDNA synthesis Kit (Fermentas, Canada). q-PCR analyses
were carried out using the FastStart Universal SYBR Green
Master Mix (Roche, USA) and 7500 real-time PCR (Applied
Biosystems). cDNA, corresponding to 50 ng total RNA,
served as a template in a 20-μL reaction mixture containing
primers and SYBR Green Master mix. Individual samples
were measured in triplicate. q-PCR reaction conditions and
primer sequences are described in Supplementary Table S1.
The relative expression value for each target gene was calcu-
lated as a gene quantity divided by a normalization factor
(NF), which was derived from GeNorm software (http://
medgen.ugent.be/~jvdesomp/genorm/), using GAPDH and
TBP as the reference genes. Each primer pair was validated
against the reference gene primers with a serial dilution of a
reference cDNA sample from the tissues to be analyzed.
Protein Expression Levels in Ileum Analyzed by ELISA
and Western Blotting
ELISA Procedures
Approximately 100 mg of full-thickness ileum tissue sections
were homogenized in ice-cold HENT buffer (1:10) containing
a cocktail of phosphatase inhibitor (PhosStop, Roche) and
1 mM PMSF (phenylmethanesulfonyl fluoride) (Tocris
Bioscience, UK) using the Micro Tissue Grinders (T10,
IKA, Germany) on ice. Immediately, after homogenization,
the homogenates were centrifuged (K30, Sigma, Germany)
at 20,000×g for 20 mins at 4 °C. Protein expression levels of
glial cell line-derived neurotrophic factor (GDNF), brain-
derived neurotrophic factor (BDNF), neurotrophin 3
(NTF3), and GDNF family receptor alpha 1 (GFRα1) in the
supernatant fractions were measured by specific ELISA kits
(Elabscience, China), in accordance with manufacturer’s in-
structions. The protein concentration in each sample was de-
termined using the BCA protein assay (Pierce BCA Protein
Assay Kit, USA). All analyses of the ELISA and protein as-
says were carried out in triplicate. The values determined for
GDNF, BDNF, NTF3, and GFRα1 were normalized to that of
the protein concentration.
Western Blotting Procedure
Western blotting for the quantitative analyses of the expres-
sion level of target proteins was carried out as described pre-
viously [21]. Equal amounts of proteins (60 μg) were resolved
by SDS/PAGE electrophoresis using 10% polyacrylamide re-
solving gel (CREB, phospho-CREB ERK1/2, and phospho-
ERK1/2) or 7% for polySia, while 8% polyacrylamide gels
were used for resolving Akt, phospho-Akt, ribosomal S6 ki-
nases (RSKs), p90, and phospho-RSK p90. The separated
proteins were transferred electrophoretically onto a PVDF
membrane at 90 V for 1.5 h. The membrane was first blocked
by incubation with TBST (20 mM Tris, pH 7.5, 150 mM
NaCl, 0.05% Tween 20 (v/v)) containing 5% skimmed milk
for 2 h at room temperature with gentle shaking. The mem-
branes were then incubated overnight at 4 °C with primary
antibodies to mouse anti-polySia (1:1000, mAb 735), rabbit
anti-CREB and phospho-CREB (1:500, cell signaling tech-
nology), Akt and phospho-Akt (1:1000, cell signaling tech-
nology), RSK1 p90 (1:500, Abcam), phospho-RSK p90
(1:500, cell signaling technology), and ERK1/2 and
phospho-ERK1/2 (1:2000, cell signaling technology), respec-
tively (Supplementary Table S2). After extensive washing in
TBST, the membranes were incubated with secondary anti-
body (horseradish-peroxidase-conjugated anti-rabbit
1:10,000, Sigma) at room temperature for 2 h. Proteins on
the blots were detected using enhanced chemiluminescence
(CW0049A, CWBIO, China; RPN2235, GE Healthcare,
USA), after exposure to X-ray films (XBT-1, Kodak, USA).
Amouse primary antibody toβ-actin was used as a control for
the amount of protein loaded on each gel and detected using
an anti-β-actin mAb (A1978, 1:1000, Sigma, USA).
Quantitation of the protein bands was carried out by scanning
the films using the Image Analyses Software (Quantity One,
Bio-Rad, USA). The density of protein bands on all films was
determined under non-saturating conditions.
Intestinal Histological Analyses
Paraformaldehyde-fixed samples of jejunum and ileum were
dehydrated overnight in 30% sucrose, embedded in OCT
(SAKURA, Japan), sectioned in 5-μm thicknesses in a cryo-
stat microtome (LEICA CM 1950, Germany) before being
mounted on slides. For measurement of villus-crypt struc-
tures, the slides were stained with hematoxylin and eosin.
The villus area, from the tip of the villi to the villus/crypt
junction, and the crypt area were measured at × 100 magnifi-
cation using an Olympus microscope (Olympus IX 5, Japan)
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and Imagepro Plus software, in 12–15 vertically well-
orientated villus and crypts [22]. All sample analyses were
carried out blinded, such that the nature of the results remained
unknown to the investigators.
Intestinal Immunofluorescence Assay
Immunofluorescent analyses of the jejunum and ileum were
carried out on 5-μm thick slices on glass slides. After the
slides were first rinsed with water, they were incubated with
1 mg/mL sodium borohydride in phosphate-buffered saline
containing Tween 20 (PBST, 0.01 mol/L, pH 7.4) 3 times
for 10 mins at room temperature. After washing with PBST
two times for 5 mins each, the slides were incubated with a
primary rabbit, anti-Ki67 antibody (1:200, ab15580, Abcam,
USA) in an antibody dilute buffer (AR1017, Bo Shide, China)
overnight at 4 °C. The slides were then washed 3 times for
10 mins each with PBST at room temperature and then incu-
bated with secondary antibody (1:200, A11012, AlexaFluor
594, Life technology, USA). After 2-h incubation at room
temperature, the slides were washed 3 times with PBST for
15 min each at room temperature. Control sections in which
either primary antibodies or secondary antibodies were omit-
ted showed no labeling of cells. All sections were counter-
stained with DAPI (VECTA SHIELD®). The images obtain-
ed were analyzed using a fluorescence microscope (Olympus
IX 5, Japan). Cells in the ileum positive for Ki 67 were count-
ed using Image-Pro Plus software. Total quantifications were
carried out on six-independent intestine samples from each
group of piglets, and at least 30 crypts per sample were
analyzed.
Analyses of Stool Consistency
Visual assessment of stool consistency was assessed each
morning using a modified method as described previously
[20]. The detail methods of stool consistency assessment are
described in Supplementary Material.
Statistical Analyses
Comparison of the expression level of target genes and their
cognate proteins, intestinal histology, and K67 staining was
carried out using Univariate ANOVA for normal distribution
or a Tweedie generalized linear model for non-normal distri-
bution. Differences in the incidence and severity of diarrhea
were compared using a Binomial or Tweedie generalized lin-
ear model with a probiotic (Medilac-Vita, from a local
pharmacy) as a covariate. Differences in the onset of diarrhea
were compared using the Kaplan–Meier survival analysis.
Normality was assessed using the Kolmogorov–Smirnov test.
Data are expressed as mean ± SEM, and a significance level of
0.05 was used. All statistical analyses were confirmed using
the SPSS for Windows 19 Inc. Chicago, IL.
Results
Sialyllactose Upregulates the GDNF Neurotrophic
Signaling Pathway in the Ileum
GDNF is a member of a family of critically important neuro-
trophic growth factors and a key neurotrophic factor expressed
in the postnatal enteric nervous system (ENS) [23]. GDNF is
expressed in the embryonic intestine and activates the trans-
membrane receptor tyrosine kinase, Ret, and a co-receptor
GDNF family receptor α1 (GFRα1), which promotes the de-
velopment of ENS during embryonic development [24]. Our
present findings show that the mRNA level for GDNF was
upregulated 86% in the SL intervention group, compared with
the control group (P = 0.03, Fig. 1a). The NTF3 gene expres-
sion level, however, was not significantly different between
the SL intervention group and the control group of piglets
(P > 0.05). Accordingly, the protein expression level of
GDNF in the SL intervention group was significantly in-
creased in the ileum compared with the control group of pig-
lets (P = 0.02, Fig. 1b). The protein expression levels of NT3,
BDNF, and GFRα1 were not altered by SL intervention
(Fig. 1b).
GDNF signaling stimulates the phosphorylation of CREB-
1, ATF-1, and CREM-1, and c-fos transcription through a
multicomponent receptor complex [25]. To determine the ef-
fects of upregulated GDNF expression on the intracellular
activation of its downstream proteins, we examined the func-
tional consequences of the SL-induced message levels for
CREB phosphorylation (pCREB) and p90 RSK using
Western blotting. Our results show that pCREB at Ser-133
was significantly upregulated in the SL intervention group
compared with the control group (P = 0.007, Fig. 1c), indicat-
ing activation of the GDNF downstream signaling pathway.
Recent in vivo studies have demonstrated that CREB and the
CREB-binding protein (CBP) are required for intestinal stem
cell (ISC) survival while overexpressing CREB promotes cell
proliferation [26]. Similar to what was observed with CREB,
the phosphorylation of RSKs, the major CREB kinases,
showed a 14% increase in the SL-treated piglets compared
with the control (Fig. 1c).
We also determined the protein expression level of the
GDNF family receptor alpha 1 (GFR α1) and found no sig-
nificant difference between the SL intervention and control
groups of piglets (Fig. 1b).We further examined the activation
levels of the extracellular signal-regulated kinases (ERK), the
ERK downstream proteins, p90 RSK, and Akt (serine/threo-
nine-specific protein kinase, also known as protein kinase B),
which are involved in downstream effectors of GDNF/RET.
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Fig. 1 Sialyllactose intervention upregulates neurotrophin factors and
CREB in the ileum of neonatal piglets. a mRNA levels of GDNF (P =
0.03), NTF3 (P = 0.74). b Protein expression levels of GDNF (P = 0.02),
GFRα1, NTF3 (P = 0.18), and BDNF (P = 0.80). cWestern blot analyses
of the abundance levels of phospho-CREB and phospho-p90RSK, the
relative comparative level of phospho-CREB (P = 0.007), and phospho-
p90RSK after normalization to the abundance level of β-actin. dWestern
blot of the abundance level of phospho-ERK and phospho-Akt, the
relative comparative level of phospho-ERK, and phospho-Akt after
normalization to the abundance level of β-actin. e mRNA expression
level of GFAP (P = 0.08) and UchL 1(P = 0.17). Differences between
groups were analyzed using univariate ANOVA for normal distributed
data or the Tweedie generalized linear model, *P < 0.05, **P < 0.01
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However, no significant differences were found in the protein
expression levels of pERK p90 RSK and pAkt between the SL
intervention and the control group of piglets (Fig. 1d). The
molecular events linking cell surface receptors to the activa-
tion of ERKs are complex, with many different stimuli that
can activate the ERKs. For example, GDNF-stimulated PI3K
and Akt activities exert opposing effects on the ERK pathway.
RAS/ERK and PI3K signaling pathways are important for
activation of CREB in GDNF-treated cells, respectively [27].
To examine if other neurotrophic factors also contributed to
the effects of SL intervention on ENS and gut development,
we analyzed the gene expression levels of two other major
neurotrophic factors, BDNF and NTF3 in the ileum. Our find-
ings showed no statistically significant differences between
the SL intervention and control piglets (P > 0.05, Fig. 1b). In
contrast, the expression level of the enteric neuron marker,
UchL1, and the enteric glial cells marker, GFAP, was upregu-
lated 22% and 53%, respectively in the SL intervention group
of piglets compared with the control group. The overall dif-
ference, however, was only marginally significant (P = 0.17
and P = 0.08, respectively, Fig. 1e).
Sialyllactose Intervention Upregulates
the Polysialyltransferase, ST8Sia IV (PST) but Not
ST8Sia II (STX) in the Ileum of 38-Day-Old Piglets
In all mammalian cells, synthesis of polySia is catalyzed by
two polysialyltransferases, designated, ST8Sia II (STX) and
ST8Sia IV (PST), during fetal and early postnatal brain devel-
opment. ST8Sia IV is the principal polysialyltransferase
expressed in the postnatal and adult brain [28]. Our results
show that the level of ST8Sia IV gene expression was upreg-
ulated by SL intervention in the ileum (P = 0.01, Fig. 2a),
while expression of ST8Sia II was only marginally responsive
to SL (P = 0.09, Fig. 2a). We view this unexpected finding
significant because it provides new evidence for directly
linking our present study to our earlier neurobiological results
by connecting the brain and intestine, likely through the gut–
brain axis via the vagus nerve. The oligosialyltransferase,
ST8SiaIII, which catalyzes synthesis of the α-2,8-triSia moi-
ety expressed in gangliosides and several neural glycoproteins
[29], was slightly downregulated in the ileum with SL inter-
vention compared with the control (Fig. 2a).
Gene expression levels of the major protein carriers
of polySia, viz. NCAM, synaptic cell adhesion molecule
(SynCam1), and NRP 2, were upregulated by 23%,
10%, and 38% respectively, in the SL intervention
group of piglets compared with the control group
(Fig. 2b). In postnatal piglets, polySia could be detected
within the ileum and was slightly increased (~ 12%) in
piglets whose diets were supplemented with SL, com-
pared with the control piglets (Fig. 2c).
Effect of Sialyllactose Intervention on the Level
of Gene Expression Markers in Enteric Cells
of the Ilium
The effect of SL intervention on the level of gene expression
in four functional cell markers, chromogranin A (ChGA), al-
kaline phosphatase (IAP), mucin 2 (Muc2), and lysozyme
(LYZ), in the ileum, was quantitatively determined using q-
PCR (Fig. 3a, b). The mRNA levels for the cell markers of
enterocytes (IAP), goblets cells (Muc2), and Paneth cells
(LYZ) were upregulated by 10%, 26%, and 110%, respective-
ly following SL intervention compared with the control group
(Fig. 3a). No significant difference was found in the gene
marker for neuroendocrine cells (ChGA) (Fig. 3a).
We also determined the effect of SL intervention on intes-
tinal cell survival by examining changes in the expression
level of cell regulatory molecules, including caudal-type ho-
meobox 2 (CDX2) and epidermal growth factor receptor
(EGFR). As shown by our q-PCR results, the mRNA levels
of CDX2, a critical regulator of intestinal cell proliferation and
intestinal epithelial maturation [30], were upregulated ca. 25%
by SL intervention. EGFR, a marker of cell proliferation, in-
creased by ca. 31% in the SL intervention group of piglets
(P = 0.09, Fig. 3b).
Effect of Sialyllactose Intervention on the Protein
Expression Level of Ki67: a Marker for Cell
Proliferation
In the intestinal crypts of piglets, epithelial stem cells and
multipotent progenitor cells were proliferating and showed
nuclear staining for Ki67, a marker for cell proliferation [31]
(Fig. 4a). Quantitative analyses showed that the number of
Ki67+ proliferating cells per crypt was significantly higher in
the SL intervention group (P = 0.04, Fig. 4b), and the number
of Ki67+ proliferating cells per crypt depth was also increased
by dietary SL intervention (P = 0.03, Fig. 4c). Thus, these
results demonstrate that dietary SL intervention enhances cell
proliferation in the intestinal crypts of neonatal piglets.
Effect of Sialyllactose Intervention on Intestinal
Histomorphology
H&E stained sections of the jejunum and ileum of neonatal
piglets showed that piglets whose diet was supplemented with
SL had a 16% larger crypt area and a 7% larger crypt depth in
the ileum, compared with the control group (Fig. 5a, b). In
addition, after SL intervention, the crypt width in the ileum
increase by ca. 10% compared with the control group (P =
0.08, Fig. 5c). However, SL intervention had no effect on the
area of the intestinal villus, villus height, or the villus height
and crypt depth ratio (Fig. 5d–f).
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Sialyllactose Intervention Protects Piglets
from Weaning Diarrhea
Diarrhea is the manifestation of a disturbed intestinal
environment, characterized by nutrient malabsorption
and dehydration, which can impose long-term and irre-
versible consequences on the infants’ well-being. In the
present study, we found that SL intervention significant-
ly reduced the incidence of diarrhea in piglets during
the first 38 days following birth (Fig. 6a, P = 0.046,
binomial generalized linear model, with probiotic as a
covariate). However, the onset of diarrhea between the
SL intervention and control group of piglets showed no
significant difference (P = 0.17, Fig. 6b). We also ana-
lyzed the severity of diarrhea using a fecal consistency
score based on a scale from 0 to 3. Our findings
showed a ~ 24% reduction in the severity of diarrhea
in the SL intervention group of piglets, compared with
the control group (P = 0.03, Fig. 6c).
Discussion
The presence of SMOS in human milk has been shown to be a
significant health benefit for the neonate. For example, orally
administered SMOS promotes growth and metabolic changes
indicative of improved nutrient utilization [32]. Although the
role of milk SL on intestinal development has been extensive-
ly studied, the molecular and cellular processes underlying its
function in protecting the neonate are poorly understood. To
better understand these molecular processes, we administrated
3′-SL and 6′-SL to neonatal piglets at a critical stage in their
intestinal maturation from 3 to 38 days of age. For several
reasons, the neonatal piglet is the preferred and well-
accepted preclinical animal model for translational studies ap-
plicable to the human infant, particularly for studies relative to
intestinal growth and function and cognitive neurodevelop-
ment [33]. Our present findings have shown that SL interven-
tion upregulated the GDNF neurotrophic factor-signaling
pathway for both transcription and posttranslation in the
ENS, and the intrinsic innervation of the gastrointestinal tract.
GDNF is a key neurotrophic factor in the control of neuron
survival and differentiation of postnatal enteric neurons [34]
and is involved in the self-renewal of epithelial cells [35].
Previous studies have suggested that during intestinal devel-
opment, GDNF is expressed in the intestine and its signaling
to RET- and GFRα1, genes encoding a member of the GDNF
receptor family of proteins, that directs the development of the
ENS during embryonic development [36]. More recently, it
has been reported that the pleiotropic function of GDNF is, in
part, governed by modulating the level of the intracellular
activation of the GDNF downstream pathways [23].
We have further characterized the GDNF signaling path-
way to determine the status of the downstream proteins in the
extracellular signal-regulated kinases, ERK, and the CREB,
and the phosphorylated CREB, pCREB, using qPCR and
Western blot analyses. CREB, a transcription factor down-
stream of GDNF signaling, is recognized as a critical regulator
of gene expression in the central nervous system (CNS) and
the ENS [37], because it contributes to neuronal plasticity,
long-term potentiation, memory, fear conditioning, circadian
rhythm entrainment, and neuron survival [38]. Our findings
thus show that the level of pCREB at Ser-133 was upregulated
in neonatal piglets by SL intervention compared with the con-
trol group of piglets. These results suggest that SL interven-
tion activates the GDNF downstream signaling pathway, and
results in the activation of the transcription factor, CREB, to
optimize intestinal development and maturation in neonatal
piglets. However, we did not find that SL intervention activat-
ed the GDNF receptor, GFRα1, or the extracellular signals,
ERK or AKT. There was no significant effect of SL interven-
tion on ERK may be because ERK is involved in many extra-
cellular signaling pathways, including a range of growth fac-
tors, G protein-coupled receptors (GPCRs), and iron status
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Fig. 3 Effects of sialyllactose intervention on four functional cell markers
between SL intervention piglets and the control group of 38-day-old
piglets. a mRNA level of the four functional intestinal cell markers:
chGA, IAP, Muc2, and LYZ. b Intestinal maturation markers: CDX2
and EGFR. Differences between the two groups were analyzed using
univariate ANOVA
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[39]. Although GFRα1 is the main GDNF receptor, the family
of GDNF receptors also includes GFRα24 and GDNF family
receptor alpha-like may contribute to activation of GDNF sig-
naling pathway by SL intervention. Further, GDNF signaling
may operate through activation of polySia-NCAM to initiate
activation of the proto-oncogene tyrosine-protein kinase, Fyn,
leading to the phosphorylation of CREB [40]. PolySia-
NCAM mediated mRet-independent GDNF signaling and
can also lead to downstream FAK activation [41]. We found
that the level of polySia in the ileum was ~ 12% greater in the
SL intervention group of neonatal piglets compared with
control piglets. Activation of pCREB in the ileum implies that
it may be involved in optimizing intestinal development by SL
intervention, a new finding that has not, to our knowledge,
been previously described.
SL can be hydrolyzed by neuraminidases during paracellular
transport, presumably via the vagus nerve, and the dietary Sia can
be transported via blood, to the brain and other tissues, where it is
utilized in the Golgi-dependent glycosylation pathway for syn-
thesis of CMP-Sia, the activated precursor of Sia required for
sialylation of all sialylated glycans, including polySia, which
posttranslationally modifies NCAM, SynCAM, and NRP2 [28].
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Fig. 4 Sialyllactose intervention
increased the level of cell
proliferation marker of Ki67 in
the ileum of 38-day-old piglets. a
Immunofluorescent staining of
Ki67 showed increased
proliferation activity in the ileum
of SL intervention group of
neonatal piglets in comparison to
the control group (DAPI blue,
Ki67 red). b Number of Ki67-
positive cells per crypt (P =
0.047). c Number of Ki67-
positive cells per length of ileum
crypt (P = 0.035). Images are
representative of 6 piglets per
group. Original magnification
was (× 100). Results are
expressed as mean ± SEM (n = 6
animals per group). Differences
between the 2 groups were
analyzed using univariate
ANOVA, *P < 0.05
Mol Neurobiol (2019) 56:7994–80078002
In the brain, polysialylation of NCAM is catalyzed by one
of the two polysialyltransferases, either ST8Sia II or ST8Sia
IV, as noted above PolySia-NCAM functions in a number of
critical roles to modulate cell–cell interactions important for
neuronal outgrowth, synaptic connectivity, learning, and
memory formation [42]. Our present findings show that the
transcription levels of ST8Sia IV in the ileum of neonatal
piglets were upregulated > twofold by SL intervention in the
intestine of 38-day-old piglets (P < 0.05), while ST8Sia II was
increased only ~ 30% compared with the control group of
piglets. These findings confirm our previous published studies
showing that Sia intervention significantly increased the
Fig. 5 Effect of sialyllactose intervention on the histomorphology of the
jejunum and ileum in the neonatal piglets. a Crypt area, b crypt depth, c
crypt width, d. villus area, e villus height, f VH/CD; values are means ±
SEM. The villus-crypt structures were measured at × 100 magnification
using an Olympus microscope. Differences between the two groups were
analyzed using univariate ANOVA
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mRNA levels in the hippocampus encoding for ST8Sia IV in
developing piglet [43]. Interestingly, the increased transcrip-
tional level of ST8Sia IV and ST8Sia II resulted in a ~ 12%
increase in polySia in the ileum tissue in developing neonatal
piglets. As we have described previously, there is a lack of
correlation between transcription levels of ST8Sia II and
ST8Sia IV and the posttranslational levels of polySia-
NCAM in different regions of the piglet’s brain during post-
natal development [44, 45]. Thus, our present studies show
that the cellular levels of mRNA encoding for ST8Sia II and
ST8Sia IV, genes encoding for several proteins, and the level
of polySia expression are also tissue specific.
ST8Sia III, an oligosialyltransferase principally responsible
for the synthesis of the di- and triSia glycans on both neural
gangliosides and several neural glycoproteins, was downregulat-
ed by ca. 50% following SL intervention. These findings suggest
that SL interventionmay thusmodulate polySia glycan synthesis
to promote the migration of enteric precursors during the devel-
opment of ENS, in contrast to di- and triSia glycans synthesis.
Therefore, we conclude from these findings that SL modulates
polySia glycan synthesis not only in the brain but also in the
intestine. To our knowledge, this unexpected finding has not
been previously reported and is significant because it links
neural/brain function with and intestinal maturation.
Development and maturation of the ENS persist in postnatal
life, and the plasticity of the postnatal ENS is influenced by
neurotrophins, including BDNF, NTF3, and GDNF. While
GDNF is a critically important neurotrophin for postnatal enteric
neuronal survival and plasticity; the enteric glia cells are involved
in most intestinal functions, including digestion and absorption,
motility, mucosal secretion, and host defense [46]. Previous cell
culture studies have reported that SL interventionmay also affect
intestinal epithelial cell proliferation and induce differentiation in
epithelial crypt cells [11].More recently, Hoischer et al. used HT-
29 and Caco-2Bbe cell lines as models of crypt–villus axis and
reported that 6′SL caused a dose-dependent inhibition of cell
proliferation in undifferentiated HT-29 cultures and well-
differentiated Caco-2Bbe cells [47]. Importantly, however, there
are no reported in vivo studies designed to study the molecular
processes underlying the effect of SL intervention on intestinal
cell maturation and digestive functions.
As intestinal proliferation is a primary factor for intestinal
growth and development, we analyzed the role of SL interven-
tion on intestinal proliferation in vivo using the Ki67 immuno-
fluorescence assay. Our results show that SL intervention in neo-
natal piglets increased intestinal crypts proliferation at 38 days
after birth by 33%. In addition, the level ofmRNA expression for
CDX2 and EGFR, critical regulators of intestinal epithelial mat-
uration [30], was upregulated 25% and 32%, respectively after
SL intervention, compared with the control group of neonatal
Fig. 6 Sialyllactose intervention prevented weaning diarrhea in neonatal
piglets. a Reduced incidence of weaning (non-infectious) diarrhea (P =
0.046). b Onset of weaning diarrhea (P = 0.03, Cox regression with
medication as covariance). c Severity of weaning (non-infectious)
diarrhea (P = 0.03). The statistical analyses of panels (a) and (c) were
carried out using the generalized linear model as described in the text,
*P < 0.05
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piglets. Collectively, these findings show that SL intervention
increased expression of the intestinal crypt proliferation marker,
Ki67, in the ileum, promoted crypt and villus integrity, and also
increased intestinal epithelial cell proliferation. Accordingly,
compared with the previous finding that SL intervention may
inhibit intestinal epithelial cell proliferation and induce differen-
tiation in epithelial crypt cells in vitro [11], our new in vivo
findings lead us to postulate that additional molecular processes,
other than the direct effect of SL on epithelial cells, mediates the
effects of SL intervention on intestinal cell proliferation in neo-
natal piglets. Significantly, this is the first study to investigate the
molecular mechanisms of SL intervention on intestinal prolifer-
ation in neonatal piglets.
The early weaning transition is commonly associated
with increased occurrence of enteric diseases and diar-
rhea. Although the ability of SL intervention to protect
against infection and diarrhea was first attributed to its
attachment to pathogenic bacterial species [48], there is
increasing evidence that the sialyl moiety of SL may di-
rectly modulate the intestinal cell properties [47] and en-
hance the development and function of the CNS [49].
Further, our study shows that SL intervention can signif-
icantly improve gut comfort during weaning by reducing
the incidence and severity of early weaning diarrhea in
postnatal piglets provides the first in vivo evidence for
the protective effect of SL intervention on early weaning
diarrhea in piglets. Additionally, intestinal maturation in
the early postnatal life may be an important factor in the
protective effects of SL intervention on early weaning
diarrhea in neonatal piglets.
Although the precise molecular and cellular mechanisms of
how SL intervention upregulates GDNF expression and acti-
vates the downstream protein kinase-mediated phosphoryla-
tion of CREB remains unresolved, it is possible that the Sia
moiety of SL is a critical player for the activation of both the
GDNF and polySia-NCAM signaling pathways. This hypoth-
esis is supported by our present and previous studies, includ-
ing the following: (1) Sia is an essential conditional nutrient
for neural development and cognitive function for the new-
born [43] and also for proper neuron function in the ENS in
the elderly [49]; (2) Sia is a key sugar component of sialylated
milk oligosaccharides, glycoproteins, and gangliosides in hu-
man milk, where 69–82% of the Sia is conjugated as oligo-
saccharides [12]; (3) polysialylation of NCAM is involved in
enteric precursor migration and neurite formation [50] and has
been reported to mediate Ret-independent GDNF signaling
[41]; (4) as shown in this study, expression levels of both
GDNF and ST8Sia IV are upregulated by SL intervention.
These findings imply that the interaction between GDNF
and polySia-NCAM is associated with the beneficial effect
Fig. 7 Proposed pathway and molecular mechanism by which milk
sialyllactose intervention may influence intestinal maturation. (1)
Exogenous SL upregulated the expression level of mRNA and protein
for GDNF in the ileum; (2) dietary SL intervention also provides a major
source of Sia to activate gene expression levels of ST8Sia IV for the
synthesis of polySia on NCAM in the ileum. (3) PolySia mediates
binding to GDNF, which activates Fyn to increase expression levels of
the phosphorylation of CREB [41]. (4–5) SL intervention did not directly
activate GFRa1, one of GDNF receptor and did not activate the
downstream proteins of ERK, pERK, p90 RSK, and Akt/pAkt,
Therefore, the upregulated levels of GDNF gene and protein expression
results in upregulated phosphorylation of CREB were not mediated
through activation of the Ras/ERK1/2 signaling pathway. (6) GDNF
plays a pivotal role in regulating postnatal ENS development and
epithelial cell fate [46] through upregulating the level of the
transcription factor, phospho-CREB and to promote cell proliferation,
evidence by an increase in the number and density of Ki-67 positive
cells in the crypts. SL, 3′- and 6′-sialyllactose; GDNF, glial cell line-
derived neurotrophic factor; UchL1, ubiquitin carboxy-terminal
hydrolase L1; ST8Sia IV, polysialyltransferase IV; NCAM, neural cell
adhesion molecules; polySia, polysialic acid; polySia-NCAM,
polysialylated NCAM; BDNF, brain-derived neurotropic factor, ENS,
enteric nervous system
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of SL intervention in promoting intestinal maturation in neo-
natal piglets. Our proposed molecular mechanism of how di-
etary SL intervention may influence the intestinal maturity
a n d p l a s t i c i t y t h r o u g h a CREB d e p e n d e n t ,
polysialyltransferases, and polySia-NCAM-mediates binding
to GDNF promoting cell proliferation is summarized schemat-
ically in Fig. 7.
In summary, the collective results of our current study dem-
onstrate that SL intervention can promote gut development
and prevent early weaning diarrhea in neonatal piglets by
upregulating the transcriptional and translational levels of
GDNF, CREB phosphorylation, Ki67, and ST8Sia IVexpres-
sion in the ileum of a piglet. Given the emerging importance
of the role of the “gut–brain axis” and ENS in intestinal health
and disease prevention, and the impact of SL intervention and
Sia on CNS and ENS, future studies will be required to assess
the molecular underpinnings of more precisely how SL inter-
vention may impact the “gut–brain axis” during development.
Finally, it is noted that these findings add further proof that the
neonatal piglet model is very informative in understanding the
molecular mechanisms regulating the efficacy of dietary inter-
ventional studies on intestinal maturity, neurocognition, learn-
ing, and memory for translational value to humans, in contrast
to the mouse model.
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